8-KEarnings & Results

DEXCOM INC 8-K Report, Financial Results (May 1, 2019)

Filed May 1, 2019For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on May 1, 2019, primarily to report its financial results for the first quarter ended March 31, 2019. The filing includes a press release that details the company's performance during the quarter. While the 8-K itself does not contain detailed financial tables, it incorporates by reference the press release which serves as the primary source of disclosed financial and operational information for the period. Investors should review the furnished press release for key metrics such as revenue, profitability, and any forward-looking guidance provided by the company. This report signifies DexCom's ongoing commitment to timely disclosure of material events, particularly its financial performance, which is crucial for understanding the company's trajectory and value. The information provided is furnished and not deemed 'filed' under Section 18 of the Exchange Act.

Key Highlights

  • 1DexCom reported its first-quarter 2019 financial results on May 1, 2019, via an 8-K filing.
  • 2The 8-K filing incorporates a press release (Exhibit 99.01) containing the detailed quarterly financial and operational results.
  • 3This filing serves as a notification of the company's performance update for the period ending March 31, 2019.
  • 4The information is furnished under Item 2.02 and is not considered 'filed' for certain regulatory purposes.
  • 5Investors are directed to the press release for the specific financial details and any accompanying commentary.
  • 6The report ensures transparency regarding DexCom's performance in the first quarter of 2019.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce DexCom, Inc.'s financial results for the first quarter ended March 31, 2019, and to furnish the accompanying press release that contains these details.

The specific financial results for the first quarter of 2019 are detailed in the press release dated May 1, 2019, which is furnished as Exhibit 99.01 to this 8-K filing and incorporated by reference.

The 8-K filing itself does not contain forward-looking guidance, but the accompanying press release (Exhibit 99.01) may include such information. Investors should refer to the press release for any guidance provided by DexCom.

When information is furnished under Item 2.02 of Form 8-K, it means it is provided to the SEC for informational purposes but is not subject to the liabilities under Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated into other SEC filings like the Securities Act or Exchange Act filings. This distinction is important for legal and regulatory compliance.